nk 252 has been researched along with 1,4-dihydropyridine in 1 studies
| Studies (nk 252) | Trials (nk 252) | Recent Studies (post-2010) (nk 252) | Studies (1,4-dihydropyridine) | Trials (1,4-dihydropyridine) | Recent Studies (post-2010) (1,4-dihydropyridine) |
|---|---|---|---|---|---|
| 11 | 0 | 8 | 1,115 | 23 | 221 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kiue, A; Kohno, K; Kuwano, M; Takano, H; Watanabe, Y | 1 |
1 other study(ies) available for nk 252 and 1,4-dihydropyridine
| Article | Year |
|---|---|
Potentiation of etoposide and vincristine by two synthetic 1,4-dihydropyridine derivatives in multidrug-resistant and atypical multidrug-resistant human cancer cells.
Topics: Antineoplastic Agents; Cell Survival; Dihydropyridines; Dioxins; Drug Resistance; Drug Synergism; Etoposide; Humans; Intracellular Fluid; Neoplasms; Tritium; Tumor Cells, Cultured; Vincristine | 1991 |